Author

S. Ricklefs

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Organism:human· 1

Frequent Co-Authors

C. Martens· 2 shared A. Nath· 1 shared B. Smith· 1 shared B. Williamson· 1 shared C. S. Sauter· 1 shared C. Yinda· 1 shared D. Adney· 1 shared D. E. Sturdevant· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

C. Martens

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Imbalanced immune response and dysregulation of neural functions underline fatal opportunistic encephalitis caused by astrovirus

O. A. Maximova, M. L. Weller, T. Krogmann, D. E. Sturdevant, S. Ricklefs, K. Virtaneva, C. Martens, K. Wollenberg, M. Minai, I. N. Moore, C. S. Sauter, J. N. Barker, I. Lipkin, D. Seilhean, A. Nath, J. I. Cohen

This study investigates astrovirus-induced CNS infection in immunocompromised patients, showing immune dysregulation and neural dysfunction similar to HIV.

bioRxiv · Aug 20, 2022 · PreprintMicrobiology

ChAdOx1 nCoV-19 (AZD1222) protects Syrian hamsters against SARS-CoV-2 B.1.351 and B.1.1.7 1 disease

R. Fischer, N. van Doremalen, D. Adney, C. Yinda, J. Port, M. Holbrook, J. Schulz, B. Williamson, T. Thomas, K. Barbian, S. Anzick, S. Ricklefs, B. Smith, D. Long, C. Martens, , V. Munster

This study shows that the ChAdOx1 nCoV-19 vaccine protects Syrian hamsters from SARS-CoV-2 B.1.1.7 and B.1.351 variants, preventing weight loss, lung lesions, and viral replication.

bioRxiv · Mar 11, 2021Microbiology